Home › Funds › ALGEBRIS (UK) LTD › PCGPRX

ALGEBRIS (UK) LTD position in PCGPRX

PG&E CORP

ALGEBRIS (UK) LTD reported holding 365,000 shares of PCGPRX (PG&E CORP) in its Q3 2026 13F filing — a position valued at US$11.3M, representing 0.63% of its reported portfolio and ranking #40 among its reported holdings. ALGEBRIS (UK) LTD has disclosed PCGPRX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)365.00K sh
Reported value held$11.26M
Portfolio Weight0.63%
First reportedQ4 2024
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How ALGEBRIS (UK) LTD's PCGPRX position evolved

ALGEBRIS (UK) LTD first disclosed a stake in PCGPRX in Q4 2024 at 505,000 shares (US$24.3M). The position peaked in Q1 2025 at 665,000 shares, worth US$27.5M. Across 8 filings, ALGEBRIS (UK) LTD increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 365,000 shares valued at US$11.3M. Notable position changes include a 32% increase in Q1 2025, a 45% trim in Q2 2025.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 505.00K $24.28M New
Q1 2025 665.00K $27.54M Add
Q2 2025 365.00K $13.70M Reduce
Q3 2025 365.00K $14.36M Hold
Q4 2025 365.00K $14.83M Hold
Q1 2026 365.00K $15.52M Hold
Q2 2026 365.00K $14.92M Hold
Q3 2026 365.00K $11.26M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PCGPRX and 13F data

PCGPRX (PG&E CORP) is a company whose sector is not yet classified in our data. 40 other funds we track also report a position in PCGPRX — the largest reported positions include Aequim Alternative Investments LP (US$78.0M), CREDIT INDUSTRIEL ET COMMERCIAL (US$55.0M), Sculptor Capital LP (US$46.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PCGPRX

All PCGPRX fund holders →

FAQ

How long has ALGEBRIS (UK) LTD held PCGPRX?

ALGEBRIS (UK) LTD has disclosed PCGPRX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is ALGEBRIS (UK) LTD's current position in PCGPRX?

As of Q3 2026, ALGEBRIS (UK) LTD holds 365.00K shares of PCGPRX (PG&E CORP), valued at $11.26M, representing 0.63% of its reported portfolio and ranking #40.

Has ALGEBRIS (UK) LTD been buying or selling PCGPRX?

In the latest 13F filing (Q3 2026), ALGEBRIS (UK) LTD held unchanged its position in PCGPRX. The position peaked in Q1 2025 at 665.00K shares.

Which other funds hold PCGPRX?

Other major institutional holders of PCGPRX include Aequim Alternative Investments LP, CREDIT INDUSTRIEL ET COMMERCIAL, Sculptor Capital LP, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.